CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

NEW
FRA:1CG (Switzerland)   Ordinary Shares
€ 43.02 -1.425 (-3.21%) Jul 14
At Loss
P/B:
2.68
Market Cap:
€ 4.36B ($ 5.01B)
Enterprise V:
€ 2.91B ($ 3.34B)
Volume:
154.00
Avg Vol (2M):
262.00
Trade In:

CRISPR Therapeutics AG Operating Data

CRISPR Therapeutics AG Competitors' Latest Operating Data

Operating data not available.

CRISPR Therapeutics AG (FRA:1CG) Operating Data Charts